These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22245556)

  • 1. Modulation of GITR for cancer immunotherapy.
    Schaer DA; Murphy JT; Wolchok JD
    Curr Opin Immunol; 2012 Apr; 24(2):217-24. PubMed ID: 22245556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for anti-GITR cancer immunotherapy.
    Knee DA; Hewes B; Brogdon JL
    Eur J Cancer; 2016 Nov; 67():1-10. PubMed ID: 27591414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of anti-GITR-based combination immunotherapy.
    Zappasodi R; Sirard C; Li Y; Budhu S; Abu-Akeel M; Liu C; Yang X; Zhong H; Newman W; Qi J; Wong P; Schaer D; Koon H; Velcheti V; Hellmann MD; Postow MA; Callahan MK; Wolchok JD; Merghoub T
    Nat Med; 2019 May; 25(5):759-766. PubMed ID: 31036879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting GITR in cancer immunotherapy - there is no perfect knowledge.
    Davar D; Zappasodi R
    Oncotarget; 2023 Jun; 14():614-621. PubMed ID: 37335294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
    van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
    Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of CTLA-4 and GITR for cancer immunotherapy.
    Avogadri F; Yuan J; Yang A; Schaer D; Wolchok JD
    Curr Top Microbiol Immunol; 2011; 344():211-44. PubMed ID: 20563707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, OX40, GITR, CD27, CD28, and ICOS.
    Sanmamed MF; Pastor F; Rodriguez A; Perez-Gracia JL; Rodriguez-Ruiz ME; Jure-Kunkel M; Melero I
    Semin Oncol; 2015 Aug; 42(4):640-55. PubMed ID: 26320067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New emerging targets in cancer immunotherapy: the role of GITR.
    Buzzatti G; Dellepiane C; Del Mastro L
    ESMO Open; 2020 Aug; 4(Suppl 3):e000738. PubMed ID: 32817129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assays for effector T cell functions and activity of immunomodulatory antibodies.
    Zappasodi R; Budhu S; Abu-Akeel M; Merghoub T
    Methods Enzymol; 2020; 631():43-59. PubMed ID: 31948562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Miyazaki M; Ikeda S; Tsumura H
    Oncol Rep; 2015 Oct; 34(4):1995-2001. PubMed ID: 26239052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced TNFR-related gene (GITR) as a therapeutic target for immunotherapy.
    Riccardi C; Ronchetti S; Nocentini G
    Expert Opin Ther Targets; 2018 Sep; 22(9):783-797. PubMed ID: 30107134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects.
    Schoenhals JE; Cushman TR; Barsoumian HB; Li A; Cadena AP; Niknam S; Younes AI; Caetano MDS; Cortez MA; Welsh JW
    Front Immunol; 2018; 9():2170. PubMed ID: 30294332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.
    Snell LM; Lin GH; McPherson AJ; Moraes TJ; Watts TH
    Immunol Rev; 2011 Nov; 244(1):197-217. PubMed ID: 22017440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
    Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
    J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
    Mahne AE; Mauze S; Joyce-Shaikh B; Xia J; Bowman EP; Beebe AM; Cua DJ; Jain R
    Cancer Res; 2017 Mar; 77(5):1108-1118. PubMed ID: 28122327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
    Durham NM; Holoweckyj N; MacGill RS; McGlinchey K; Leow CC; Robbins SH
    J Immunother Cancer; 2017; 5():47. PubMed ID: 28649380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
    Kim YH; Shin SM; Choi BK; Oh HS; Kim CH; Lee SJ; Kim KH; Lee DG; Park SH; Kwon BS
    J Immunol; 2015 Nov; 195(10):4721-9. PubMed ID: 26423152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR).
    Platania CBM; Ronchetti S; Riccardi C; Migliorati G; Marchetti MC; Di Paola L; Lazzara F; Drago F; Salomone S; Bucolo C
    Biochem Pharmacol; 2020 Aug; 178():114110. PubMed ID: 32569630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies.
    Furness AJ; Vargas FA; Peggs KS; Quezada SA
    Trends Immunol; 2014 Jul; 35(7):290-8. PubMed ID: 24953012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
    Nocentini G; Ronchetti S; Petrillo MG; Riccardi C
    Br J Pharmacol; 2012 Apr; 165(7):2089-99. PubMed ID: 22029729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.